Advanced Brain Monitoring, Inc.

The Apnea Risk Evaluation System (ARES) integrates physiological data acquired in-home with clinical history and anthropomorphic data to determine presence and severity of Obstructive Sleep Apnea (OSA).The ARES System incorporates the ARES Unicorder headset worn by the patient, the ARES Screener questionnaire and the ARES Software and/or diagnostic services. The ARES has been approved by the United States Food and Drug Administration (FDA) and was validated in a large clinical study.